Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 214
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT05765006 CD19-CART(Relma-cel) for Moderate to Severe Active Systemic Lupus Eryth… |
Relma-cel | SEP | Phase 1 | UNKNOWN | En attente / non publié | Shanghai Ming Ju Biotechnology Co… | China · Relma-cel Medical, Shanghai, China | 2023-02-24 → 2025-12-30 | Ouvrir |
| NCT07331467 Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE |
CD19 CAR-T cells | SEP | Phase 1 | RECRUITING | En attente / non publié | Chongqing Precision Biotech Co., … | China · Affiliated Drum Tower Hospital, Medical Schoo… | 2026-01 → 2028-08 | Ouvrir |
| NCT07260877 AERIS — A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ph… |
VENT-03 | Lupus | Phase 2 | RECRUITING | En attente / non publié | Ventus Therapeutics U.S., Inc. | United States, Bulgaria, France, Georgia, Hungary, Po… | 2025-12-03 → 2027-03 | Ouvrir |
| NCT05352919 EMERALD — A Study to Learn More About the Long-Term Safety of Litifilim… |
Litifilimab | Lupus | Phase 3 | ENROLLING_BY_INVITATION | En attente / non publié | Biogen | United States, Argentina, Belgium, Brazil, Bulgaria, … | 2022-06-10 → 2032-05-03 | Ouvrir |
| NCT06434363 Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepl… |
Tafasitamab | Lupus | Phase 1/2 | RECRUITING | En attente / non publié | M.D. Anderson Cancer Center | United States · MD Anderson Cancer Center, Houston, U… | 2024-07-31 → 2030-12-31 | Ouvrir |
| NCT07104344 Study of CM355 in Patients With Systemic Lupus Erythematosus |
CM355 | Lupus | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Second Xiangya Hospital of Centra… | China · Second Xiangya Hospital of Central South Univ… | 2025-09-25 → 2027-09-01 | Ouvrir |
| NCT04868838 Daratumumab to Treat Active Lupus Nephritis |
Daratumumab | Lupus | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Mayo Clinic | United States · Mayo Clinic in Rochester, Rochester, … | 2021-04-20 → 2027-01 | Ouvrir |
| NCT03747159 SynBioSe-2 — Synergetic B-cell Immunomodulation in SLE - 2nd Study. |
Belimumab Injection | Lupus | Phase 3 | COMPLETED | En attente / non publié | Leiden University Medical Center | Netherlands · HagaZiekenhuis, The Hague, Netherlands … | 2018-10-01 → 2026-06-22 | Ouvrir |
| NCT07829497 Pain Phenotyping of Rheumatic Diseases - An Observational Study |
Bedside quantitative sensory test… | Lupus | À vérifier | NOT_YET_RECRUITING | En attente / non publié | National Institute of Arthritis a… | United States · National Institutes of Health Clinica… | 2026-10-14 → 2036-06-15 | Ouvrir |
| NCT07276958 A Study of LY4298445 in Healthy Participants and Participants With Syst… |
LY4298445 | Lupus | Phase 1 | RECRUITING | En attente / non publié | Eli Lilly and Company | Australia, China, Japan · Anhui Provincial Hospital, … | 2026-02-04 → 2028-03 | Ouvrir |
| NCT07355218 A Study of Enpatoran in Participants With Cutaneous Manifestations of L… |
Enpatoran | Lupus | Phase 3 | RECRUITING | En attente / non publié | EMD Serono Research & Development… | United States, Australia, Brazil, Bulgaria, Canada, C… | 2026-04-01 → 2029-05-25 | Ouvrir |
| NCT07332481 ELOWEN-1 — A Study of Enpatoran in Participants With Cutaneous Manifest… |
Enpatoran | Lupus | Phase 3 | RECRUITING | En attente / non publié | EMD Serono Research & Development… | United States, Australia, Brazil, Bulgaria, France, G… | 2026-03-10 → 2029-05-24 | Ouvrir |
| NCT07629583 To Evaluate the Effects of Cevostamab in Participants With Systemic Lup… |
Cevostamab | Lupus | Phase 1 | RECRUITING | En attente / non publié | Genentech, Inc. | France, Spain · Hopital Rangueil, Toulouse, France | … | 2026-10-31 → 2030-03-29 | Ouvrir |
| NCT06828042 Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refrac… |
anti-CD19 CAR T cell therapy | SEP | Phase 1/2 | RECRUITING | En attente / non publié | Peking University Third Hospital | China · Peking University Third Hospital, Beijing, Ch… | 2025-07-01 → 2027-12-31 | Ouvrir |
| NCT07782450 A Study to Learn About a Medicine Called PF-08154225 in Participants Wi… |
PF-08154225 | Myopathies | Phase 1/2 | NOT_YET_RECRUITING | En attente / non publié | Pfizer | Non communiqué | 2026-11-19 → 2031-02-22 | Ouvrir |
| NCT07844200 Bela-SLE — The Primary Objective of the Trial is to Evaluate the Effect… |
belantamab mafodotin to the exist… | Lupus | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Medical Association for the Study… | Non communiqué | 2027-02 → 2031-12 | Ouvrir |
| NCT07038447 A Study of KITE-363 in Participants With Refractory Autoimmune Diseases |
KITE-363 | Lupus | Phase 1 | ENROLLING_BY_INVITATION | En attente / non publié | Kite, A Gilead Company | United States, Australia, Canada, South Korea · ASAN … | 2025-07-02 → 2030-09 | Ouvrir |
| NCT05411016 A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupu… |
KK4277 | Lupus | Phase 1 | COMPLETED | En attente / non publié | Kyowa Kirin Co., Ltd. | Japan, South Korea · Ajou University Hospital, Suwon,… | 2022-08-03 → 2025-10-27 | Ouvrir |
| NCT04643067 Lupus — Phase 1b/2a Study to Evaluate Safety and Efficacy of KPG-818 in… |
KPG-818 low dose in phase 1b | Lupus | Phase 1/2 | COMPLETED | En attente / non publié | Kangpu Biopharmaceuticals, Ltd. | United States · Accurate Clinical Management, Houston… | 2021-06-03 → 2023-06-29 | Ouvrir |
| NCT07299422 A Study of SHR-2173 in Participants With Systemic Lupus Erythematosus |
SHR-2173 injection | Lupus | Phase 2 | RECRUITING | En attente / non publié | Guangdong Hengrui Pharmaceutical … | China · Chinese Academy of Medical Sciences, Peking U… | 2026-04-03 → 2028-11 | Ouvrir |
| NCT07083349 NK510 Cell Therapy for Refractory Systemic Lupus Erythematosus |
NK510 : allogeneic genetic modifi… | Lupus | Phase 1 | TERMINATED | En attente / non publié | Base Therapeutics (Shanghai) Co.,… | China · The First Affiliated Hospital of Anhui Medica… | 2025-12-01 → 2026-04-01 | Ouvrir |
| NCT07799116 CART-NEL — Study to Evaluate the Safety and Preliminary Efficacy of CD1… |
TranspoCART19 | Lupus | Phase 1/2 | RECRUITING | En attente / non publié | Instituto de Investigación Sanita… | Spain · Clinica Universidad de Navarra, Pamplona, Spa… | 2026-09-23 → 2030-09 | Ouvrir |
| NCT07855302 CD19 CAR-T Therapy for Refractory Childhood-Onset Systemic Lupus Erythe… |
SNUH-CD19-CAR-T Cells | Lupus | Phase 1 | RECRUITING | En attente / non publié | Seoul National University Hospital | South Korea · Seoul National University Hospital, Seo… | 2026-09-14 → 2028-12 | Ouvrir |
| NCT06133972 SIRIUS-SLE LTE — Phase 3 Extension Study to Evaluate Long-term Safety o… |
Ianalumab | Lupus | Phase 3 | RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Argentina, Australia, Brazil, Bulgaria… | 2024-05-21 → 2034-10-02 | Ouvrir |
| NCT04976322 A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol … |
Dapirolizumab pegol | Lupus | Phase 3 | ENROLLING_BY_INVITATION | En attente / non publié | UCB Biopharma SRL | United States, Argentina, Belgium, Bulgaria, Canada, … | 2021-07-27 → 2030-08-07 | Ouvrir |